Raleigh clinical-stage pharmaceutical developer Innovate Biopharma is merging with Israel-based RDD Pharma to create a new company, 9 Meters Biopharma. Here’s a look inisde the deal.
Read More
A roundup of headlines from Triangle and NC companies making news in tech and life science.
Read More
Innovate Biopharmaceuticals is launching a phase 3 clinical trial for a treatment targeting celiac disease, which is hereditary and affects millions.
Read More
Under the deal, some 4.1 million shares of common stock will be sold at $4 per share, and up to 2.5 million shares at $2.56 per share.
Read More
